In Silico Exploration of Potential Inhibitors Targeting SARS ‐ CoV ‐2 Non‐Structural Protein 15 (Nsp15): A Comprehensive Overview of Current Research
Chemical Biology & Drug Design · 2025
DOI: 10.1111/cbdd.70218 ↗At a glance
Übersichtsarbeit in Chemical Biology & Drug Design, 2025. Written by Behnaz Yazdani and 11 co-authors. Institution: Bioscience Department, Faculty of Science and Technology (FCT), Universitat de Vic-Universitat Central de Catalunya (Uvic-UCC), Vic, Spain. Major MEDLINE topics: Viral Nonstructural Proteins, Antiviral Agents, Endoribonucleases. 131 references. Funded by: Isfahan University of Medical Sciences.
Abstract (original language)
The SARS‐CoV‐2 nonstructural protein 15 (Nsp15) is an endoribonuclease that plays a critical role in viral replication and immune evasion through its NendoU domain. The unique enzymatic mechanism of Nsp15 has attracted considerable attention as a potential therapeutic target, and the identification of its inhibitors could facilitate the development of novel antiviral agents against coronaviruses. Although biochemical and structural studies have provided important insights into Nsp15 function, no comprehensive review has yet focused on computational approaches applied to the discovery of Nsp15 inhibitors. Consequently, this study aims to address this gap by summarizing recent in silico research focused on the structure, function, and inhibition of Nsp15. Special attention is given to inhibitors derived from both natural and synthetic sources, as well as their binding interactions and predicted pharmacological potential. By integrating current computational findings, this review highlights novel prospects for the rational design of Nsp15‐targeted therapeutics to combat SARS‐CoV‐2 and other related pathogenic coronaviruses.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Bioscience Department, Faculty of Science and Technology (FCT), Universitat de Vic-Universitat Central de Catalunya (Uvic-UCC), Vic, Spain.
- Bioinformatics Research Center, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran.
- Department of Biochemistry, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran.
- Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
- Department of Molecular Genetics, Biological Sciences Faculty, Tarbiat Modares University, Tehran, Iran.
- Department of Microbiology, Faculty of Biological Sciences, Flavarjan Branch, Islamic Azad University, Isfahan, Iran.
ORCID profiles: Hajar Sirous, Shayan Ansarizadeh, Mohammadjavad Karimi Taheri, Ghazal Pourmohammad-Hosseini, Simone Brogi
Funding
- Isfahan University of Medical Sciences
Cite
APA
Yazdani, B., Sirous, H., Farzam, F., Ansarizadeh, S., Karimi Taheri, M., Pourmohammad-Hosseini, G., Noei, M., Daneshipour, K., Shakeri, D., Houshangi, M., Calderone, V., & Brogi, S. (2025). In Silico Exploration of Potential Inhibitors Targeting SARS ‐ CoV ‐2 Non‐Structural Protein 15 (Nsp15): A Comprehensive Overview of Current Research. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.70218
Vancouver
Yazdani B, Sirous H, Farzam F, Ansarizadeh S, Karimi Taheri M, Pourmohammad-Hosseini G, et al. In Silico Exploration of Potential Inhibitors Targeting SARS ‐ CoV ‐2 Non‐Structural Protein 15 (Nsp15): A Comprehensive Overview of Current Research. Chemical Biology & Drug Design. 2025. doi:10.1111/cbdd.70218
BibTeX
@article{Yazdani2025,
author = {Yazdani, Behnaz and Sirous, Hajar and Farzam, Farnoosh and Ansarizadeh, Shayan and Karimi Taheri, Mohammadjavad and Pourmohammad-Hosseini, Ghazal and Noei, Maryam and Daneshipour, Kosar and Shakeri, Danial and Houshangi, Maryam and Calderone, Vincenzo and Brogi, Simone},
title = {In Silico Exploration of Potential Inhibitors Targeting SARS ‐ CoV ‐2 Non‐Structural Protein 15 (Nsp15): A Comprehensive Overview of Current Research},
journal = {Chemical Biology & Drug Design},
year = {2025},
doi = {10.1111/cbdd.70218}
}
EUVIMED